课题基金 / 基金详情

Coordination and administration of the Clinical Research Unit

Coordination and administration of the Clinical Research Unit
临床研究单位的协调和管理
批准号:
234097741
负责人:
Professor Dr. Christian Reinhardt
金额:
$0.0万
依托单位国家:
德国
项目类别:
Clinical Research Units
财政年份:
2013
资助国家:
德国
项目状态:
已结题
起止时间:
2012-12-31 至 2020-12-31

项目摘要

项目成果

Professor Dr. Christian Reinhardt的其他基金

相似基金

相关文献

中文摘要
翻译
中心项目(CP1)包括CRU的协调和组织,以及医生科学家的两个轮换职位(Gerok职位)。该中心的主要目标是将基础研究转化为CLL诊断和治疗的临床应用。因此,在我们的CRU中,重要的是要有临床活跃的科学家,他们非常关注转化癌症生物学。为了促进年轻内科科学家的培训,并为他们的科学教育创造一个受保护的利基,我们将提供两个Gerok职位。这些职位将由想要中断临床训练,在我们的实验室从事科学研究项目的医生填补。在科隆分子医学中心和卓越集群(CECAD),我们在这些轮岗方面有很好的经验。此外,关于男女平等的预算将由议长办公室管理。
英文摘要
The central project (CP1) encompasses the coordination and organization of the CRU, as well as two rotation positions for physician scientists (Gerok positions). It is a major aim of this CRU to translate basic research into clinical applications in CLL diagnostics and therapy. It is therefore important to involve clinically active scientists with a strong focus on translational cancer biology in our CRU. To promote the training of young physician scientists and to create a protected niche for their scientific education, we will provide two Gerok positions. These positions will be filled with physicians that want to interrupt their clinical training for an extended period of time to pursue scientific research projects in our laboratories. In the Center of Molecular Medicine Cologne and in the Excellence Cluster (CECAD), we have excellent experience with these rotational positions. Moreover, the budget for gender equality and will be administered by the speaker’s office.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using mouse models to identify actionable molecular liabilities in Cluster 5 DLBCL
Understanding mechanisms of drug resistance and clonal evolution in diffuse large B cell lymphoma
  • 批准号:
    417957791
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2019
  • 负责人:
    Professor Dr. Christian Reinhardt
  • 依托单位:
Dual checkpoint blockade for the treatment of KRAS- or BRAF-driven neoplastic disease
Development of synergistic combination regimens for the treatment of chemotherapy-resistant high-risk CLL
国内基金
海外基金
一种新的给药方式--耳后给药治疗内耳疾病的作用途径及机制研究
  • 批准号:
    81070780
  • 项目类别:
    面上项目
  • 资助金额:
    28.0万元
  • 批准年份:
    2010
  • 负责人:
    余力生
  • 依托单位:
冠脉内应用山莨菪碱逆转和预防急性心肌梗死介入治疗后无复流现象机制的系列研究
  • 批准号:
    30871086
  • 项目类别:
    面上项目
  • 资助金额:
    31.0万元
  • 批准年份:
    2008
  • 负责人:
    傅向华
  • 依托单位: